Salesforce is a leading cloud-based software company that specializes in customer relationship management (CRM) solutions. It provides a comprehensive suite of applications designed to help businesses manage their sales, marketing, customer service, and analytics more effectively. By leveraging innovative technologies such as artificial intelligence and automation, Salesforce enables organizations to streamline their processes, enhance customer engagement, and drive growth. The company is committed to delivering a robust platform that allows businesses of all sizes to connect with their customers and gain valuable insights from data, ultimately fostering lasting relationships and improving overall business performance. Read More
December 8, 2025 – As artificial intelligence continues its breathtaking ascent, integrating into nearly every facet of modern life, humanity finds itself at a critical juncture. The rapid evolution of advanced AI is not just a technological marvel but a profound ethical challenge, prompting urgent global discussions on how to maintain control, manage its societal [...]
Artificial intelligence (AI) has emerged as the most significant transformative force in the advertising industry, fundamentally altering every facet of how brands connect with consumers. Far from being a fleeting trend, AI has become an indispensable, integrated component, driving unprecedented levels of personalization, efficiency, and measurable growth. The sector, while experiencing profound disruption, is demonstrating [...]
Learn how the Caviar Cruise screen identifies elite stocks like Salesforce, focusing on durable competitive advantages, high returns on capital, and strong financial health.
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
Salesforce generated free cash flow that was 22% higher YoY in its fiscal Q3. Moreover, its FCF margin rose as well. This implies that CRM stock could be at least 21% too cheap. This article will show why.
The S&P 500 Index is teetering on the brink of an unprecedented new high, propelled by a robust market rally fueled by a potent combination of encouraging inflation figures and a nuanced, yet generally improving, consumer sentiment. As of early December 2025, the benchmark index stands just a whisker
Shares of CRM software giant Salesforce (NYSE:CRM) jumped 4.4% in the morning session after the company reported better-than-expected third-quarter earnings and provided an optimistic financial outlook.
Salesforce (NYSE: CRM), the world’s #1 AI CRM, today unveiled its 2025 Cyber Week results (November 25–December 1), analyzing shopping data from over 1.5 billion shoppers. This was another record-breaking shopping week, with overall industry global sales increasing 7% year over year (YOY) to $336.6 billion, and U.S. sales accounting for $79.6 billion (up 5% YOY). These results signal a strong consumer appetite for buying this holiday season despite increasing global prices, and they demonstrate AI and agents as fundamental accelerators for purchase and productivity in commerce.
Wall Street’s headline indices barely moved on Thursday, but under the surface the story was loud and clear: U.S. consumers are trading down hard, discount retailers are loving it, and Meta is finally putting its metaverse on a diet. All of this is playing out against a backdrop of ultra-low jobless claims, a weaker dollar and growing confidence that the Fed will cut rates next week.
Salesforce (NYSE: CRM), the world’s #1 AI CRM, today announced that its board of directors declared a quarterly cash dividend of $0.416 per share. The dividend is payable January 8, 2026 to shareholders of record on December 18, 2025.
Salesforce (NYSE: CRM), the world’s #1 CRM, today announced that AstraZeneca (LSE/STO/Nasdaq: AZN), a global, science-led biopharmaceutical company, has selected Agentforce Life Sciences for Customer Engagement to help transform its customer engagement globally, fostering stronger relationships with healthcare professionals (HCPs) through data-driven, AI-powered engagement. This work will support AstraZeneca's commitment to push the boundaries of science to deliver life-changing medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, and respiratory and immunology.
The financial markets on December 4, 2025, are experiencing a dynamic session, characterized by a complex interplay of corporate earnings reports, influential analyst updates, and a barrage of new economic data. This confluence of factors is creating a volatile environment, challenging investors to decipher conflicting signals regarding the health of
